Oxygen4Life (2025)
About this raise
Oxygen4Life, with a valuation of $125 million, is raising funds on DealMaker Securities. It is a biomedicine company that leverages its partnerships with patents for people suffering from an impaired delta-6 desaturase metabolic pathway. Oxygen4Life combines FDA-cleared medical imaging, AI diagnostics, and patented therapeutic solutions to detect, track, and manage chronic diseases before they escalate. Mike Maunu and Alex Maunu founded Oxygen4Life in February 2022. The current crowdfunding campaign has a minimum target of $10,009.40 and a maximum target of $123,995.78. The campaign proceeds will be used for marketing, solutions enhancement, and operations.
Investment Overview
Not Funded: $9,945
Deal Terms
Total Commitments
- Platform
- DealMaker Securities
- Start Date
- 03/31/2025
- Close Date
- 04/30/2025
$10,009
$123,996
$298
Equity - Common
Growth Stage
RegCF
$11.91
$125,000,000
Company & Team
Company
- Year Founded
- 2022
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Sheridan, Wyoming
- Company Website
-
Visit Website
Team
- Employees
- 2
Financials
-
Revenue
-
$139,797
as of FY2023
- Monthly Burn
-
$3,894
as of FY2023
-
Runway
-
5.6 months
as of FY2023
- Gross Margin
-
42%
as of FY2023
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 01/10/2024 | DealMaker Securities | $5,000,000 | $91,630 | Equity - Common | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.